Compare BioNano Genomics Inc (BNGO) vs Box Inc (BOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Box Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while Box Inc trades at $32.86 (market cap $4.55B). The key difference: Box Inc is far larger — about 333.1× BioNano Genomics Inc's market cap, and Box Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | BOX | |
|---|---|---|
Market Cap | $13.66M | $4.55B |
Sector | Health | Technology |
52-Week High | $4.92 | $33.60 |
52-Week Low | $1.06 | $21.37 |
Enterprise Value | $16.26M | $5.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
BOX trades at $32.33, down 3.78% today, with a bullish technical outlook supported by moving averages. The company shows strong revenue growth to $1.09B in 2025 and net income of $244.62M, though valuation metrics like P/E of 51.3 appear elevated. Recent news highlights Box's AI content management capabilities, including a partnership with Quintas Energy announced July 30, 2026.
The stock offers upside to the $37 consensus price target, supported by 60.7% analyst buy ratings. Key risks include high valuation multiples and competitive pressures in cloud content management. Positive cash flow trends and earnings beats in three of the last four quarters provide fundamental support for continued growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →
